AMEXBy Dave Porter - Senior Staff RepoterSCOLR, Inc. listed its common have on the American Stock Exchange low the ticker symbol DDD. Trading began Friday.Visit our AXcess News Forum and add your comments on this story. Try your assistance at writing, the best programme will be published on our programme network. Take our upbeat poll too!Print This PageFebruary 6, 2004 (AXcess News) Redmond WA - Biopharmaceutical company, SCOLR, Inc. (AMEX: DDD) was authorised for trading on the American Stock Exchange Friday, Feb. 6.John McGonegal, grownup vice president of the Amex Equities Group said in an announcement Friday, "We look nervy to working with SCOLR in building increased investor awareness and saliency within the investment community."Daniel O. Wilds, President and CEO of SCOLR, said, "With the move from the over-the-counter bulletin board to this major domestic exchange, the Company has the opportunity to attract a broader investor base and to attract institutionalised investment interest."SCOLR, Inc. had previously traded on the OTC Bulletin Board low the symbol SCLL. Redmond-based SCOLR Inc., formerly famous as Nutraceutix Inc., it had sold the terminal of its rural business assets to Lallemand Animal Nutrition of North America of Milwaukee, Wis., a subsidiary of Lallemand Inc. of Montreal, Quebec in February 2003.SCLOR has focused since then on developing supplements for manlike intestinal health, famous as probiotics; and take conveying systems for any number of upbeat issues. The consort said it has devised a conveying grouping for its probiotics supplements, which allows the consort to deliver the product in preventive form.

Supplements To Build Muscle

That system, patented as Controlled Delivery Technology platform, could make the conveying of drugs of other types more efficient. For example, if a person needs to take three pills per period low a certain take regimen, the SCLOR grouping might be able to turn that number to digit preventive per period by control the rate at which the body absorbs the drug.The Company said that on Dec. 12 a domestic merchandiser had placed its prototypal order for digit newborn products using the grouping in 12-hour formulations of Niacin and EsterC. SCOLR did not identify the retailer, which plans to delude the pills low its own private label.In Jan SCOLR announced that it had united to delude digit of its digit divisions for most $2.72 million.Steven Moger, the chief business tar and general trainer of the division, united to buy it.SCOLR said it has planned on the understanding of the division for some time, though it has historically generated most of the company's revenues.

Bodybuilding Diet Plan For Men

The division existence sold makes dietary attach pills for the maintenance of manlike intestinal health.Terms of the deal call for Moger to resign his function as an tar of SCOLR and pay $720,000 in cash at the time the deal closes. The newborn consort would make deferred payments of at small $2 million more, and added amounts are equal to sales levels and royalties.Moger's consort has been acknowledged the right to ingest SCOLR's CDT technology in the manufacture of certain products, the consort said.No information was acquirable as to Moger's future plans for his newborn consort in regards to becoming a publically traded consort through reverse integration or IPO.While SCOLR sought liquidity through Curb listing, trading was well received by investors Friday, pushing AMEX: DDD shares up 23 cents, or 7.49 percent, to near at $3.30 on intensity of 63,500 shares. The 90-day cipher regular intensity was reportable to be $0.82 to $3.70.The specialist appointed by the Curb in SCOLR, Inc. is Cohen Specialists L.L.C.AXcess News will be programme on any newborn mart trends related to this story. Members should check their in-box for late breaking news. If you're not a member, study joining now. Members get the latest business news, commentaries and have picks delivered right to their in-box.